Back to MS MSD Partners, L.P.
NBRV
Showing 0 of 6 quarters
Position history for MSMSD Partners, L.P.'s holdings in NABRIVA THERAPEUTICS PLC
As of its Q3 2020 13F, MSD Partners held 50,000 shares of NBRV (Nabriva Therapeutics), worth $27,000. MSD Partners' 13F filings listed NBRV from Q3 2019 to Q3 2020, 5 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.